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HYPERACTIVITY DISORDER 
by 
NICHOLE LAFORTUNE  
(Under the Direction of Tamerah Nicole Hunt) 
ABSTRACT 
Context: Participants with Attention Deficit Hyperactivity Disorder (ADHD) have 
shown cognitive impairments that affect coordination, anticipation and planning. In 
the ADHD population, stimulant medication has shown to have beneficial outcomes 
for 75% of the people.  Unfortunately, in most research, patients with ADHD are 
excluded and little is known about this population.   
Purpose: Determine the effects of stimulant medication in recreationally active 
ADHD participants on reaction time.   
Design: Cross-section between groups design  
Methods: Participants were divided into two groups (ADHD and controls). Upon 
arrival to the Biomechanics Lab participants performed two tests, Mode A and Mode 
D on the Dynavision D2 (Dynavision International LLC, 2016). Mode A consisted of 
three practice trials, followed by five test trials.  Mode D consisted of one practice 
trial, followed by seven test trials for each of the three tasks.  After completion of all 
tests, participants completed an effort debriefing.  ADHD participants performed one 
session “on medication” and one session “off medication.”  The controls performed 
both trials at the same interval with no use of medication.  Group differences were 
calculated using a mixed model repeated measures analysis of variance (ANOVA) 
using SPSS 23.0 software (SPSS Inc. Chicago, IL). Additionally, paired-sample t-
tests were calculated to examine ADHD participants “on” verses “off” medication 
and differences in reaction time variability (RTV).   
Results: 34 participants (n=21 controls, n=13 ADHD) completed all testing.  A 
statistically significant difference existed between groups for Mode A (F(1,32)=13.12, 
p=0.01, Λ=0.71, η=0.29, Cohens D= 0.94), Mode D-Direct (MDD) (F(1,32)=5.61, 
p=0.015, Λ=0.85, η=0.15, Cohens D= 0.632), Mode D-Circle (MDC) (F(1,32)=3.41, 
p=0.011, Λ=0.90, η=0.10, Cohens D= 0.433) and Mode D-Horizontal (MDH) 
(F(1,32)=2.30, p=0.05, Λ=0.93, η=0.07, Cohens D= 0.31), with controls demonstrating 
faster reaction times.  A statistically significant difference was found for medication 
use during MDC (t(12)=2.35, p=0.04), with ADHD participants demonstrating slower 
reaction times when off their medication.  There was a statistically significant 
difference for RTV for MDD (t(12)=2.199, p=0.05) on and off their medication.   
Conclusion: The use of stimulant medication does not appear to consistently effect 
reaction time performance.  In a recreationally active population, participants with a 
self-reported diagnosis of ADHD perform slower than controls on reaction time tests.  
These slower performances could be due to task complexity (inter stimulus intervals), 
movement patterns of ADHD participants, as well as type of ADHD.  Future research 
should investigate ADHD in Division I college athletes in regards to reaction time 
(RT) and reaction time variability (RTV) and the effect of ADHD on athletic 
performance. 
INDEX WORDS: Attention Deficit Hyperactivity Disorder, Reaction time variability, 
ADHD medication, Choice Reaction Test, Simple Visual Reaction Test. 
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CHAPTER 1 
 
INTRODUCTION 
 
Attention Deficit Hyperactivity Disorder (ADHD) is a neurodevelopmental/ 
neurobehavioral disorder defined by chronic and impaired behavior patterns that cause abnormal 
attention, focus, hyperactivity, impulsivity, and disorganization.1–4  ADHD can present in three 
different subtypes; predominantly inattentive presentation, predominantly hyperactive/impulsive 
presentation or a combined presentation.1,3,5  There is no known cause of ADHD, although there 
are several hypotheses addressing the physiological aspects of this disorder.  These hypotheses 
range from reduced volume and functionality of gray and white matter in the brain,6 to reduced 
function of the prefrontal cortex (PFC), caudate, and cerebellum in ADHD patients.7,8   
There appears to be a rise in the rates of ADHD diagnoses consistently since 2003.  From 
2003 to 2011, the rate of ADHD diagnoses in children increased from 7.8% to 11% 
respectively.9  These diagnosis rates have increased on average approximately 3%-5% per year 
from 1997 to 2011.9  Unlike most psychiatric disorders that are diagnosed in adulthood, ADHD 
is first diagnosed during childhood, however, symptoms can persist into the adolescents and 
adulthood years.4  Research suggests that as high as 80% of individuals with ADHD continue to 
show symptoms into their adolescent and adult years.2,10  It is estimated that 2.5% to 4.5% of 
adults in the United States have been diagnosed with ADHD, and 3.4% of adults worldwide 
demonstrate ADHD symptoms.1,11  With such a large amount of the adult ADHD population 
continuing to show symptoms into the adult years make this population an interest for many 
research endeavors.     
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While there appears to be noticeable differences within the ADHD population, one 
important difference appears in motor performance.12  Previous research reports children and 
adolescents with ADHD commonly have poor coordination, balance, and motor ability.13–16   
Research has suggested that children with ADHD may be at a higher risk for movement skill 
difficulties.16  When looking at children with ADHD, in terms of fitness and fundamental gross 
motor skills, they are below average when compared to non-ADHD matched individuals.15  The 
presence of these deficits associated with ADHD can affect motor performance and coordination 
having a direct impact on their ability to react.  This idea of affected motor performance is 
interesting as again most of this research is done in the childhood and adolescent years.  Which 
begs the question; is there motor differences in adults with ADHD?  One way to assess motor 
differences is to do so by looking at reaction time.   
Significant research has examined the effect of ADHD on reaction time.  Reaction time 
(RT) is defined as, “the time it takes to initiate a response after a sensory stimulus has been 
brought about.”17  A simple reaction is a task in which an individual performs the same response 
to a single stimulus every trial.18–20  A complex reaction involves more than one stimuli and/or 
response across different trials.18  It is common for patients with ADHD to have slower and more 
variable RTs off their medication when compared to normal controls.21,22  Reaction time 
distributions tend to be positively skewed especially for individuals with ADHD resulting in 
abnormally slower responses.23  Additionally, individuals with ADHD show increased reaction 
time variability (RTV) across a large range of tasks.24–27 
RTV is described as “an inconsistency in a person’s responding speed, which is measured 
in seconds or milliseconds.”24–27  RTV is attributed to periodic lapses of attention, these occur 
randomly and periodically, causing slower responses in people with ADHD.23,28–30  This inability 
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to respond could be due to the lapse in attention requiring longer reaction times.31  Like 
previously stated, individuals with ADHD show increased RTV across many ranges of tasks, 
some include; reaction time motor speed, choice decision, vigilance, behavioral inhibition, 
cognitive interference, working memory, visual saccade and visual discrimination.24–27  With the 
use of stimulant medication, some of these deficits have shown improvements.  Once a stimulant 
medication has been used, there is a rapid and predictable decrease in disruptive symptoms and 
an increase in attentiveness shown.32  Benefits of stimulants include attention and concentration 
improvements as well as fine motor coordination and balance.10  Stimulant medications may 
have the ability to enhance task efficiency.16  Stimulants have been associated with large 
decreases in RTV, showing that patients with ADHD significantly improve or normalize RTV. 23  
With the use of ADHD medication, specifically stimulant medications, most studies show there 
to be an acceleration of mean RT and reduced RTV in children and adults with ADHD.33  
Further, when ADHD participants are off or discontinue stimulant medication use, they have 
demonstrated slower movement preparation.22    
 Drug therapy, especially stimulant treatments, are the most common and effective 
treatment and management of ADHD.34–38  Approximately 56% of people with ADHD are being 
treated by pharmacological methods, specifically stimulant medication.39  There are concerns 
about stimulant medication and their advantages for patients with ADHD compared to non 
ADHD population.34  The advantages that are currently being discussed do not have to do with 
advantages in sport, but rather advantages in regards to school/work/social situations.  One study 
showed that when prescribed a stimulant medication, there was a 75% improvement in behavior, 
academic performance, cognitive performance and socialization.40  One study explained that 
children who play baseball, who take stimulant medication have admitted to having a mindset 
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that the medication will help improve their performance with cognition and physicality.41  This is 
a perceived mindset that children have admitted to, no research has been done looking at if the 
adult athletic population feels there is perceived mindset of better performance.     
Many studies are regularly looking at both children and adolescents in this area of 
research.30  There has been little to no research looking at the adult population of people with 
ADHD.  There is even less research done in regards to looking at people who are physically 
active.  With that being said, some elite athletes with ADHD are perceived as having an unfair 
advantage in competition.16  This perceived advantage leads to the question: “Do stimulant 
medications give participants with ADHD an advantage in performing in elite sports 
performance?”  With there being no research in the ADHD population in regards to physical 
activity, the first step that may be necessary is to look at recreationally active individuals with 
ADHD and analyze differences that may be seen in RT and RTV.  There is still a need for the 
assessment of reaction time in physically active individuals with and without ADHD, as well as, 
the effects of stimulant medication on fundamental movement and reaction.16  With little 
research done in this area, the purpose of this study was to look at recreationally active 
individuals with self-reported ADHD and assess their reaction time, while on and off their 
medication and compare those results to a control group of typically developing recreationally 
active individuals.   
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CHAPTER 2 
Methods  
Participants 
Participants were taken from a convenience sample of recreationally active college 
students.  The participants were divided into two groups: a control group (n=21) and a group that 
self-reported a diagnosis of Attention Deficit Hyperactivity Disorder (ADHD) (n=13).  The 
controls came from the same recruitment process as the ADHD participants, however, they 
denied having a diagnosis of ADHD.   
Inclusion criteria for the ADHD group: 1) 18-25 years old, 2) have a self-reported ADHD 
diagnosis with prescribed stimulant medication and 3) recreationally active.  The inclusion 
criteria for the control group include: 1) 18-25 years old, 2) recreationally active and 3) must not 
have a diagnosis of ADHD.  The exclusion criteria for controls and ADHD group include: 1) any 
musculoskeletal or head injury in the last 6 months, 2) patients with prescribed non-stimulant 
medication, 3) mental health comorbidities such as anxiety or depression, 4) prescribed 
medications for other comorbidities (high blood pressure, narcolepsy, asthma, etc.) 5) smokers, 
6) use of alcohol or within 24 hours of testing, and 7) ADHD individuals who consistently take 
their medication and are unable normally function without the use of medication.   
Instrumentation:  
Dynavision (International LLC, 2016) 
The Dynavision D2 is a light training reaction device developed to train sensory and 
motor integration through the visual system.42  The Dynavision is a visuomotor training device 
that was used to assess the participant’s reaction time.  It is a 120cm x 165cm training surface 
that consists of 64 illuminating buttons.  These buttons are arranged in five nested rings 
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surrounding a LCD screen located in the middle of the device.43  The device can be raised and 
lowered depending on the height of the participant.  The participant stands at a self-selected 
distance where they can easily reach all the lights and would then perform the selected tests.  
There are mixed reports of Dynavision Intraclass correlation coefficient (ICC) ranges 
across modes.  For Mode A studies, ICC values range from 0.75-0.88.43,44  For Mode D, the 
ICCs vary depending on the measure (visual reaction time reliability versus motor reaction time 
variability).  Mode D’s visual reaction ICC was 0.84 and the motor reaction ICC was less at 
0.63.44  Speed and digit task techniques when using the Dynavision found a reliability of 0.71 
and 0.73.45  Initial improvements in reaction time trials when using the Dynavision have been 
attributed to a learning effect.43 
Mode D (Choice Reaction Test) 
Mode D has the ability to assess both motor as well as visual reaction time.  Visual 
reaction time is measured as the amount of time it takes the participant to identify the stimulus 
and initiate their reaction by removing their hand from the home button.  The motor response 
time is measured by the amount of time it takes the participant to physically strike the 
illuminated button as quickly as possible, after removing their hand from the home button.  The 
amount of time between the hand leaving the home button to striking the new button is the motor 
reaction time.44  The outcome of combining the motor reaction time with the visual reaction time 
is the physical reaction time.  For the purposes of this study, we will examine physical reaction 
time.   
Standard procedures for this test, suggest the participant complete one practice test for 
each of the three tasks of Mode D.  The three tasks included a straight line stimulus response 
(Mode DH), a circle stimulus response (Mode DC) and a direct stimulus response (Mode DD).  
14 
 
 
The participant stood at a self-selected distance where they could easily reach all of the lights.  
This position was measured and recorded to ensure the participant was at the same position 
during follow-up testing.  The measurements were taken from the tip of the participants toe to 
the base of the Dynavision board.   
Before starting each of the three tasks (Mode DH, Mode DC, Mode DD), the potential 
responses that could be struck were displayed for the participant to see prior to the start of the 
test.  The participant then held down the red “home” button to start the first task.  Once the 
“home” button was held down a new stimulus appeared within 2-4 seconds of holding down the 
home button.  Once the new stimulus appeared, the participant removed their finger from the 
home button and hit the new stimulus as quickly as possible.  For example, during Mode DH, the 
participant would hold down the red home button and then respond to a single stimulus in a 
horizontal pattern.  After each of the individual responses, the researcher wrote down the 
physical reaction time.  After the information was recorded, the researcher instructed the 
participant to again hold down the home button to continue with the testing.  This process was 
repeated for one practice trial and seven test trials.  Once Mode DH was complete, the researcher 
then progressed to the next task by hitting the green button.   
The next task consisted of the semi-circle stimulus response (Mode DC).  The participant 
was given 20-40 seconds rest in between each of the three tasks. 43  The semi-circle stimulus 
response task also had one practice trial followed by seven test trials.  The participant held down 
the home button and tried to strike the new stimulus as quickly as possible.  The participant 
waited to proceed until they were instructed to do so by the researcher.  The previously described 
procedures for Mode DH were followed for Mode DC, but the potential stimuli were arranged in 
a semi-circular pattern rather than a horizontal line.  After the participant completed the semi-
15 
circle test trials the researcher progressed by hitting the green button to reach the last task of this 
test program.  The participant continued to Mode DD.  For the direct task, the participant knew 
exactly which button was going to illuminate in 2-4 seconds after holding down the home button.  
The participant had one practice trial followed by seven trials.44   
Mode D visual reaction time has shown strong reliability with an ICC ranging from 0.73-
0.84.  The motor reaction time of Mode D has moderate reliability having an ICC of 0.63. 44  
Wells et al. showed no significant differences between consecutive sessions,44 indicating there 
was less of a learning curve present during Mode D tasks.  The absence of a learning curve could 
be due to the lack of task complexity with this test program.42      
Mode A (Simple Visual Reaction Test) 
Mode A has the ability to assess average RT over a one minute period.  The standard test 
protocol for Mode A requires the participants to stand at a self-selected distance where they can 
easily reach all the lights and can peripherally see the lights on the outer rings.  This spot was 
measured from the bottom of the board to the tip of the participants toe to ensure the participant 
was in the same position for retesting.  Once the participant was in a comfortable position they 
were instructed that they could use both hands and were instructed to try to use either the front or 
the back of their hand throughout the entire test.  Whichever part of their hand they decided to 
use for the first test session, they were instructed to use the same technique for follow-up testing.   
Then the testing process was ready to begin.  The participant was then instructed to try to keep 
their eyes focused on the middle of the Dynavision looking at the LCD screen.  Mode A is able 
to assess reaction time using mostly your peripheral vision.  The researcher then counted down 
from five to start Mode A.  With the participants eyes focused on the LCD screen, the 
Dynavision showed a stimulus on the board, the participant then struck the button that was red as 
16 
quickly as possible, while keeping their focus on the LCD screen.  Once the stimulus had been 
struck, the red light relocated to another location on the board, where the participant must then 
strike the new stimulus at the new location as quickly as possible.  This continued for a one 
minute period.44  The participant had three practice trials followed by five test trials.  Mode A 
has a moderate to strong ICC ranging from 0.68-0.75.44   
Effort Debriefing 
Following the Dynavision testing there was a simple effort debriefing (Appendix D).  
Within the effort debriefing, the researcher asked the participant to rank on a 0-6 scale (with zero 
representing they did not try at all and six representing their best effort) regarding how hard they 
felt they tried.  This was used to assess people who did not put forth any effort and could 
potentially be eliminated from the study.  There were also probing questions for the participants 
such as: “Were there any points in which you felt you stopped trying your hardest? If so, which 
sections?”  “Did you feel as if you lost attention/interest during any of the testing sessions? If, so 
which sections?”  “Do you feel your loss of attention/ interest affected your effort?” 
Procedures: 
Pilot Testing: 
Pilot testing was completed prior to participant recruitment.  This determined the feasibility 
of the test protocol and allowed competence in administration, as well as examining the 
participants’ ease of understanding the instructions.  Pilot testing was done on Division I NCAA 
athletes with ADHD as well as controls, with no diagnosis of ADHD.  The test protocol was 
replicated as previously explained utilizing both Mode A and Mode D.  The pilot subjects then 
went through the effort debriefing discussion with the researcher.     
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General Procedures:  
Participants were recruited through flyers that were distributed and displayed in Hanner, 
Hollis, the Student Disabilities Resource Center (SDRC) and the student health center.  
Recruitment through health sciences classes was also completed to enhance recruitment 
numbers.  Once the researcher was contacted by a potential participant, a follow up call/email 
was made to discuss inclusion and exclusion criteria.  At this time, ADHD participants disclosed 
their regular medication habits regarding when they take their medication.  The researcher also 
discussed whether the potential participant took any “medication holidays” (i.e., days they 
choose not to take their medication).  The researcher determined the testing sessions that were 
considered to be “off” based upon their normal medication regiment.  To have the ability to test 
participants with ADHD for their “off medication” trial testing either occured during a time they 
did not regularly take the medication or testing occurred prior to taking their normal medication 
intake.  There were no points in the study where the researcher asked the ADHD participants to 
not take their medication.  Their “off medication” trial was scheduled around the time of their 
normal medication patterns.   
Once all criteria were met, the participants were enrolled in the study.  Test sessions for 
the ADHD group were based around their medication use and controls testing sessions occurred 
during best availability times.  Prior to the first test session, participants arrived to the 
biomechanics lab and filled out consent forms, as well as demographic sheets (Appendix D).  
The participants were assigned ID numbers, for confidentiality purposes, that only the researcher 
had access to decoding.  When ADHD participants arrived to each session, the ADHD 
participants had to validate their medication use.  The researcher determined if the ADHD 
participants had taken their medication during “on medication” trials.  The researcher also 
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verified the “off medication” trials by asking the participants if they did not take their medicine 
that day.  After all appropriate information was obtained, the participants performed Mode A and 
Mode D tests on the Dynavision. This process took approximately 20 minutes per test session.   
Test sessions and test trials were counterbalanced.  The medication trials were also 
counterbalanced for ADHD participants.  This process was completed by randomly selecting 
ADHD participants to be “on medication” first and “off medication” for their second test trial 
and vice versa.  This reduced the likelihood of practice effects overshadowing the medication 
effects.  The order of testing was also counterbalanced for all participants.  This was 
accomplished by randomly assigning the test protocols that would be performed first (Mode A or 
Mode D).  Counterbalancing the medication trials and test protocols reduced the likelihood of 
finding differences as a result of only practice effect or fatigue.   
After all the testing protocols were completed, there was a posttest effort debriefing.  
During the debriefing the researcher discussed the participant’s effort and attention/interest 
during the testing.  A follow-up appointment for the second test session was scheduled within 
48-72 hours after the first testing session.  During the second test session, the participants 
repeated the same testing protocol.  Once all the data were collected, the information was put 
into IBM Statistical Package for Social Sciences Software (SPSS) Statistic 23 software (SPSS 
Inc. Chicago, IL).   
Data Analysis:  
This is a cross-sectional between groups design.  The independent variables for this study 
are group (ADHD and Controls) and the testing session (on medication verses off medication).  
The dependent variables were reaction time outcomes of the individual tests as well as reaction 
time variability.   
19 
Statistical Analysis: 
Statistical analysis was calculated using IBM SPSS Statistics 23 software (SPSS Inc, 
Chicago, IL).  Statistical assumptions that were accounted for were sphericity, independency of 
cases, normality, and variance of equality or homogeneity.  This study used a 2 (group) x 2(time) 
mixed model repeated measures analysis of variance (ANOVA) to compare ADHD participants 
to controls.  A paired-samples t-test was also run to compare ADHD participants on and off 
medication trials.  For RTV the coefficient of variance (COV) was taken for ADHD participants 
for Mode A and Mode D.  Then a paired-sample t-test was run to find the variability of the COV 
for ADHD participants on and off their medication.  All alpha levels were set a priori at 0.05.  
The effect size was calculated using the partial eta squared.  Prior to calculations, the researcher 
examined normality, outliers and assumptions. 
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CHAPTER 3 
 
RESULTS 
 
Thirty-four participants (n=13 ADHD, n=21 controls) completed this study.  There was a 
total of 21 females and 13 males who participated in this study.  Participants ranged from 18 to 
24 years of age with a mean of 21.91 + 1.69 years.  The average time between test sessions 
ranged from 48 to 72 hours with the mean time being 53.64 + 10.33 hours.  No participants were 
excluded due to lack of effort, with the cut off score being a three on the effort debriefing.  Eight 
of the thirteen participants with ADHD felt as if they had a loss of attention during testing.  Of 
those eight, six stated that they felt their loss of attention affected their effort.  For the ADHD 
participants the most common medications used were Adderall (5 participants) and Vyvance (5 
participants).  The range of use of medication for these participants ranged from one to five years 
of usage.  Sleep for the ADHD participants ranged from five hours of sleep to nine hours of 
sleep.  The controls had similar sleep patterns ranging from four and a half hours of sleep to nine 
hours of sleep.  The effort ranges for test sessions and additional demographic information can 
be found in Table 1.   
Table 1: Demographics.  
Demographic  ADHD (SD) Control (SD) 
Age 21.15 (2.19) 22.38 (1.12) 
Weight  73.06kg (41.26) 74.71kg (33.90) 
Height  173.11 cm (9.32) 171.87 cm (13.92) 
Effort 4.5-6 4-6 
Males 6  7 
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Females 7 14 
  
MODE A: 
Significant differences between the ADHD group and controls were seen (F(1,32)=13.12, 
p=0.01, Λ=0.71, η=0.29, Cohens D= 0.94) during Mode A, where controls had a faster reaction 
time compared to ADHD participants (Table 2, Figure 1, Figure 2).  A significant difference was 
found for the effect of medication (F(1,32)=13.12, p<0.001, Λ=0.71, η=0.29, Cohens D= 0.94) 
between ADHD and controls, with controls performing better compared to ADHD participants 
both on and off medication.  A paired-sample t-test revealed no significant difference in ADHD 
participants on and off medication (t(12)=2.08, p=0.06). 
Reaction time variability was calculated in the ADHD group across medication use for 
Mode A.  A paired-sample t-test revealed no significant differences (t(12)=0.644, p=.532) in 
variability of patients with ADHD on and off medication for Mode A.  The mean difference for 
Mode A was (Mon-Moff=0.014611).   
 
Table 2: Means and Standard Deviations of Mode A.   
 Group Mean  Standard Deviation  
Mode A ADHD (OFF) 0.90 0.12 
 Control 0.78 0.13 
Mode A ADHD (ON) 0.83 0.11 
 Control 0.74 0.12 
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Mode D-Direct (MDD):  
Significant differences were seen between ADHD participants and controls (F(1,32)=5.61, 
p=0.015, Λ=0.85, η=0.15, Cohens D= 0.632) during Mode D-Direct, where controls had a faster 
reaction times compared to ADHD participants (Table 3, Figure 3, Figure 4).  A significant 
difference was found for the effect of medication (F(1,32)=5.61,p=0.02, Λ=0.85, η=0.15, Cohens 
D= 0.632) between ADHD and controls.  A paired-samples t-test revealed there was no 
significant differences in ADHD participants on and off medication (t(12)=1.78, p=0.10).   
Reaction time variability was calculated in the ADHD group across medication use for 
Mode DD.  A paired-sample t-test revealed significant differences (t(12)=2.199, p=0.05) in 
variability of patients with ADHD on and off their medications for Mode DD.  The mean 
difference for Mode D-Direct was (Mon-Moff=0.063158).   
Table 3: Means and Standard Deviations of Mode D-Direct. 
Group Mean Standard Deviation 
Mode DD ADHD (OFF) 0.65 0.09 
Control 0.56 0.13 
Mode DD ADHD (ON) 0.60 0.12 
Control 0.52 0.08 
Mode D-Circle (MDC): 
Significant differences were seen between ADHD participants and controls (F(1,32)=3.41, 
p=0.011, Λ=0.90, η=0.10, Cohens D= 0.433) during Mode D-Circle, where controls had a faster 
reaction times compared to ADHD participants (Table 4, Figure 5, Figure 6).  There was no 
significant difference found for the effect of medication (F(1,32)=3.41, p=0.07, Λ=0.90, η=0.10, 
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Cohens D= 0.433) between ADHD participants and controls.  A paired-samples t-test revealed a 
significant difference on and off medication (t(12)=2.35, p=0.04), where ADHD participants 
completed reaction time tasks faster on medication (Figure 9).   
Reaction time variability was calculated in the ADHD group across medication use for 
Mode DC.  A paired-sample t-test revealed no significant differences (t(12)=0.713, p=0.489) in 
variability of patients with ADHD on and off their medications for Mode DC.  The mean 
difference for Mode DC was (Mon-Moff=0.027155).   
Table 4: Means and Standard Deviations of Mode D-Circle.   
 Group Mean  Standard Deviation  
Mode DC ADHD (OFF) 0.87 0.11 
 Control 0.74 0.14 
Mode DC  ADHD (ON) 0.80 0.06 
 Control 0.72 0.15 
 
Mode D-Horizontal (MDH): 
 
Significant differences were seen between ADHD participants and controls (F(1,32)=2.30, p=0.05, 
Λ=0.93, η=0.07, Cohens D= 0.31) during Mode D-Horizontal, where controls had faster reaction 
times compared to ADHD participants (Table 5, Figure 7, Figure 8).  There was no significant 
difference found for the effect of medication (F(1,32)=2.30, p=0.14, Λ=0.93, η=0.07, Cohens D= 
0.31) between ADHD participants and controls.  A paired-samples t-test revealed no significant 
difference in ADHD participants on and off medication (t(12)=1.18, p=0.26).   
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Reaction time variability was calculated in the ADHD group across medication use for 
Mode DH.  A paired-sample t-test revealed no significant differences (t(12)=1.148, p=0.273) in 
variability of patients with ADHD on and off their medications for Mode DH.  The mean 
difference for Mode DH was (Mon-Moff=0.028274).   
Table 5: Means and Standard Deviation of Mode D-Horizontal.    
 Group Mean  Standard Deviation  
Mode DH ADHD (OFF) 0.78 0.11 
 Control 0.69 0.15 
Mode DH  ADHD (ON) 0.73 0.10 
 Control 0.67 0.12 
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Figure 1: Mode A: ADHD participants off medication compared to controls. 
 
 
Figure 2:  Mode A: ADHD participants on medication compared to controls. 
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Figure 3: Mode D Direct: ADHD participants off medication compared to controls. 
 
 
 
Figure 4: Mode D Direct: ADHD participants on medication compared to controls. 
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Figure 5: Mode D Circle: ADHD participants off medication compared to controls. 
 
 
Figure 6: Mode D Circle: ADHD participants on medication compared to controls. 
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Figure 7: Mode D Horizontal: ADHD participants off medication compared to controls. 
 
 
Figure 8: Mode D Horizontal: ADHD participants on medication compared to controls. 
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Figure 9: Comparing mean RT of ADHD participants during Mode DC on and off medication.   
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CHAPTER 4 
 
DISCUSSION  
 
The purpose of this study was to determine the effects of stimulant medication on 
reaction time in recreationally active individuals with self-reported Attention Deficit 
Hyperactivity Disorder (ADHD) and compared those to normal controls.  We found significant 
differences between ADHD participants and controls during all reaction time tasks.  Our controls 
reaction times appear to be normal when compared to research done with recreationally active 
individuals without ADHD (Mode A: 0.683 seconds, Mode D: 0.55 seconds).44  Problems with 
motor coordination, sequencing, working memory, mental computation, planning, anticipation 
and many others are commonly seen in the ADHD population.12  While, Mode DC was the only 
task that showed significant differences between ADHD participants on and off their medication.  
Both Mode DH and Mode DD have not been consistent due to small sample sizes.  It is common 
for ADHD patients to have slower and more variable RTs than normal controls when off their 
medication.21,22  Further there was only significant differences in variability seen in Mode DD.   
Mode A: 
Mode A allows us to look at an average RT over a one minute period.  Significance 
differences existed between ADHD participants and controls, with controls demonstrating faster 
reaction times regardless of ADHD medication usage.  It appears that participants with ADHD, 
in general, have slower reaction times.  These findings suggest that even with the help of ADHD 
medication, recreationally active participants with ADHD to not have normalized RTs compared 
to controls.  This finding was not surprising as research that children with ADHD show poor 
quality of movement when compared to typically developed children and tend to have less 
precise and stable movement during tracking tasks.22,46  Theoretically, children with ADHD 
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should show a significantly positive skew in their reaction time distributions due to poor 
concentrations.21,23 
During the examination of ADHD participants and medication use, we found no 
significant difference in reaction time due to the effect of medication.  On average, there was a 
trend for slower performance in reaction time when comparing ADHD participants “off 
medication” reaction times to their “on medication” reaction times.  This finding match 
published research that states children with ADHD have slower movement preparation off their 
medication.22  With the use of ADHD medication, specifically stimulant medications, the 
research shows an acceleration of mean RT.33  When RT is looked at as a dependent variable, 
medication seemed to make RTs faster.  Further, research suggests that medication improves 
control of inhibition and the executive control of attention.34  This research supports our findings 
that ADHD medication should improve RT.     
Much of the research in patients with ADHD examining reaction time revolves around 
reaction time variability (RTV).23,31,46  24–27  Reaction time variability is attributed to periodic 
lapses of attention.  These occur randomly and periodically, causing slower responses in ADHD 
persons.23,28–30  In the current study, reaction time variability (RTV) did not show significant 
variability for Mode A.  This lack of variability is not consistent with majority of the research on 
RTV.  For Mode A there was no noted decrease in variability when looking at means either 
(Mode A on x̅:0.358, Mode A off x̅:0.344).  A potential reason why this would not be consistent 
with the literature could be due to type of ADHD.  Kofler et al.23 performed a meta-analysis and 
found that ADHD-combined type were significantly more variable when compared to ADHD-
inattention and ADHD-hyperactive.23  There is the possibility the lack of attention did not occur 
due to the type of ADHD the participant was diagnosed with.     
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Mode D: 
Mode D allows us to examine physical reaction time of a single response, by looking at 
both visual and motor reaction times.  Within testing of Mode D, we found significant 
differences between ADHD and controls during all tasks (MDD, MDC, MDH).  It appears that 
ADHD participants have slower reaction times then people without ADHD.  This is supported in 
the literature that ADHD children show less precise and less stable movement patterns during 
purist task.47  Further, timing of movements of ADHD groups tend to be more variable and 
slower.48   
MDC was the only task, during Mode D, which showed a significant difference when 
comparing ADHD participants on medication to their off medication trials, with participants 
performing faster on medication.  This appears to be consistent with the literature, supporting 
medication usage improves reaction time and attentiveness.  Drug therapy, especially stimulant 
treatments, are the most common and effective treatment methods for ADHD.34–38  Simulants 
prove to be helpful for 75% of the ADHD patients who use them.49  Once a stimulant medication 
has been used, there is a rapid and predictable decrease in disruptive symptoms and an increase 
in attentiveness shown.32  Stimulant medication improved not only fine motor skills, but reaction 
times in ADHD participants.50,51  Although we only found significance in medication effect 
during MDC, there are several reasons to why this may be the case for MDC and not MDH or 
MDD.   
One study examined the time between stimuli with inter stimulus intervals (ISI) when 
observing RT.  As ISIs become longer, medication exerted a greater effect with RTs becoming 
slower, less variable and less positively skewed.  The medication effect became linearly larger 
with increasing ISI of only 1sec, 2sec, and 4sec.21  This could explain why there were differences 
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seen between each of the Mode D trials.  There was an inconsistent stimuli response time 
ranging from 2-4 seconds for each task and the stimuli being randomly timed and displayed.  
Some participants had the potential to have gotten stimuli appearing in a shorter time frame 
causing there to be less differences when comparing medication usages.  While other ADHD 
participants relied heavily on their medication to maintain focus to respond to stimuli, that may 
have been separated by the 4 second interval.  As ISI increased, participants tend to make fewer 
errors and have slower and more variable reaction times. 21   
Evidence suggests that reaction time speed showed significantly more slowing in non-
medicated groups compared to medicated groups as the ISI increased.21  When delays in stimuli 
occur the ability to not choose a stimulus may distract the ADHD person and cause them to be 
preoccupied with a stimulus that is non-task related.31  Shorter event rates may cause an increase 
in the activation state of a person, while longer event rates may cause that underactivation.31  It 
has been stated that medication effects would become increasingly evident during longer 
intervals, which could a result of improved distractibility and attention.21  
Additionally, explanations for the differences seen between medication uses for Mode 
DC compared to the other tasks in Mode D, may be attributed to task complexity.  Research 
supports that when the movement is complex RT appears to be longer for ADHD patients off 
their medications compared to controls.46  There is sufficient evidence to support the idea that 
ADHD patients tend to have slower reaction time when the movements are complex and they 
have difficulty with motor timing, when not on medication.22  This slowing due to task 
complexity may be an effect of ADHD participants relying more heavily on visual feedback 
during movement, which results in the slower outcomes.52   
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We would be remised if we did not discuss energy.  The cognitive-energetic model of 
ADHD suggests that, energy levels of the ADHD patients when increased allows their 
performance to normalized.53,54  Having an increased energetic level can be increased by both 
intrinsic and extrinsic factors.  Extrinsic factors include making the task more challenging, for 
example when there is decreased ISI.  While an intrinsic example would be the use of a stimulant 
medication.21  Epstein, et al.21 found that both intrinsic and extrinsic manipulations caused 
ADHD participants to perform better.21  
Lastly, differences in medication use could play a role in why only MDC showed 
significance in regards to medication usage.  Although Adderall (amphetamines) and Vyvance 
(lisdexamfetamine) were the most common medications used for our participants, we did not 
have a minimum or maximum dosage amount.  Different dosages as well as type of medication, 
whether it be slow release or quick release of stimulant could affect the RT results depending on 
the time of medication intake.  The research states that Two of the most common stimulants used 
for ADHD include methylphenidate and amphetamines, which are said to be equally effective.34  
Methylphenidate has quick effects, and changes in behavior are seen within 20 to 60 minutes 
after oral consumption.  The peak effects of methylphenidate occur around 90 to 180 minutes 
and the therapeutic effects tend to subside after 4-8 hours.10  Its half-life is between 2 to 7 hours 
and is metabolized by the liver.10  Methylphenidate is said to be preferred over amphetamines 
due to its slower uptake and clearance.55  With having these differences seen in peak effects and 
half-life could truly explain differences seen in RT between participants and medication usage.   
In the current study, reaction time variability (RTV) only showed significant variability 
for Mode DD.  With Mode DD you are able to see the decrease in RTV when on medication 
(Mode DD off x̅:0.145, Mode DD on x̅:0.082).  This decrease in variability due to medication is 
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consistent within the literature.  Research tends to demonstrate large reaction time variability 
when the participants were off and on medication, where stimulants were associated with large 
decreases in RTV.23  Research establishes that medicated individuals had much less positive 
skewness than non-medicated individuals.21  This suggests that the ADHD patients on 
medication are having fewer and less severe lapses in attention due to the medication.21  
Additionally, research shows, medication appears to slow down RT and make RT less variable.21  
Subjects who have an increased positive skew in their distributions tended to have higher mean 
RT and more variability in their RT as a result.21   
Limitations:  
This study is not without limitations. First, this study has a small sample size of 
participants with ADHD. The small number of ADHD participants that were on stimulant 
medication limited the power and reduced the effect sizes seen.  This low power had the 
potential of affecting the significance of some of the results, especially with MDC when 
comparing the effects of medication of controls to ADHD patients.   
Another limitation of this study is the possibility of a practice effect seen with Mode A 
within the Dynavision.  Most of the participants in this study, controls and ADHD participants, 
performed better their second time coming in for testing. With that being seen one can conclude 
that the more a participant uses the Dynavision the better they will perform. This may mitigate 
medication use if strong practice effects exist.   
Medication used is easily another limitation for this study.  The researcher did ask the for 
the type of medication on the demographics sheet (Appendix D), but there was no exclusion nor 
inclusion criteria in terms of type of medication, dosage of medication or time of consumption of 
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medication.  These three factors have the potential to play a significant role in differences seen in 
this study.   
Lastly, we did not obtain the specific ADHD diagnosis or confirm ADHD diagnosis with 
physician notes.  Although not asked, each participant may have had a different form of ADHD, 
whether that be inattentive type, the hyperactive type or combined type.  Pitcher et al.,56 stated 
that the ADHD inattentive group showed differences compared to controls, but found no 
difference between the other subtypes of ADHD.56  That study also found differences with both 
ADHD inattentive and ADHD combined, but did not find any differences with the ADHD 
hyperactive group in regards to impaired motor skills or severe impairments to fine motor 
skills.13  
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CHAPTER 5 
CONCLUSION 
In conclusion, we found significant differences between ADHD participants and controls 
during all test measures, with controls completing tasks faster than ADHD participants.  Our 
findings support the research that ADHD patients have slower and more variable RTs than 
normal controls.21,22  ADHD patients have shown cognitive impairments and skills that fall 
outside of normal ranges.  These include executive functions, such as memory, information 
processing speed and basic motor functions.57,58  It has been regularly cited that children and 
adolescents with ADHD commonly have poor coordination, poor balance and poor motor 
ability.13–16  Examination of ADHD in children reveal below average fitness and fundamental 
gross motor skills when compared to normal matched individuals.15  The findings in this study 
are one of the first to look at the recreationally active adult population with ADHD and analyze 
their reaction time compared to normal controls.     
It seems as though medication use did not affect reaction times across all tests and only 
Mode DC may be sensitive to medication use.  The use of ADHD medication, specifically 
stimulant medications, appears to accelerate mean RT and reduce RTV.  While our study, it 
showed there were inconsistencies of medication effects seen within ADHD in this study, which 
is not consistent with the ADHD population.  The majority of research with ADHD shows 
children have poorer motor skills than typically developed peers, both with fine motor skills as 
well as gross motor skills.59  The mechanism by which medication for ADHD persons improves 
motor skills and motor control is still not clear.22  Although some children demonstrated 
improvements on medication, others did not show significance.  Moreover, there are still 
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differences seen in ADHD patients that can vary due to qualities such as type of test, type of 
ADHD, severity of ADHD, and type of medication.   
This research provides evidence that ADHD participants do indeed have slower reaction 
times compared to controls.  Future research should investigate ADHD in Division I college 
athletes in regards to RT and RTV and how it could affect their ability to participate in sports.  
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APPENDIX A 
 
Research Questions:  
1. Does reaction time differ between ADHD participants off medication compared to 
controls? 
2. Does reaction time differ between ADHD participants on medication compared to 
controls? 
3. Does reaction time differ between ADHD participants on medication verses off 
medication? 
Inclusion Criteria 
• ADHD Participants:  
o Ages 18-25 years old 
o Have a self-reported ADHD diagnosis  
o Prescribed stimulant medication  
o Must be recreationally active  
• Control Participants:  
o Ages 18-25 years old  
o Must be recreationally active  
o Must not have a diagnosis of ADHD  
Exclusion Criteria 
• Musculoskeletal or head injuries within the last 6 months 
• Patients prescribed non-stimulant medication 
• Mental health comorbidities (anxiety, depression) 
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• No other prescribed medication for other comorbidities (high blood pressure, 
narcolepsy, asthma, etc)   
• Smoking  
• Use of alcohol within 24 hours of testing 
• ADHD individuals who consistently take their medication and are unable 
normally function without the use of medication  
Limitations 
Limitations for this study are as follows: 
• Convenience Sample  
• Self-reported ADHD  
• Practice Effect of the Dynavision  
• Motivation/Effort of participants  
• Lack of Randomization  
• Sample size 
Delimitations 
Delimitations for this study are as follows:  
• Collegiate aged recreationally active individuals  
• A self-reported diagnosis of ADHD  
• Variability of prescribed stimulant medication  
Assumptions 
Assumptions researchers made during this study are as follows:  
• Equipment will work properly  
• Participants will attend both testing trials  
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• Participants will put forth their best effort  
• Participants will be honest about ADHD  
o Diagnosis  
o Type of medication  
o Time of taking medication 
Definitions 
The following definitions will be used to assist in clarification for this paper:  
• Recreationally active: participating in some form of physical activity for 20 min three 
times per week.60 
• Off medication: a day where the participant has not taken their medication within their 
normal consumption schedule 
• Effort: how hard the participant tries during testing trials  
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       APPPENDIX B 
LITERATURE REVIEW  
Introduction:  
Attention Deficit Hyperactivity Disorder (ADHD) is neurodevelopmental/ 
neurobehavioral disorder defined by chronic and impairing behavior patterns that cause 
abnormal levels of attention and focus, hyperactivity, impulsivity and disorganization.1–3,38  
Neurodevelopmental disorders are caused by a group of conditions that occur during the early 
developmental stages of life.  These disorders can be characterized by showing deficits in 
personal, social, academic or occupational functioning.1  ADHD is the most common 
neurodevelopmental disorder seen in the childhood population.3,61  Even though ADHD is one of 
the most studied childhood neurodevelopmental disorders, it still has had little attention over the 
past several years.3 
Pathophysiology: 
 There is no known cause of ADHD, but there are several hypotheses behind this disorder.  
The first hypothesis is there is reduced brain function in ADHD individuals, due to visible 
reduction in functionality and volume of gray and white matter within the brain.6   This reduction 
is thought to cause deficits in cognitive processing, as well as, deficits in attention, motor 
planning, speed of processing responses and multiple other behavioral characteristics that are 
commonly seen in persons with ADHD.6  
An alternative hypothesis consists of research showing prefrontal cortex (PFC), caudate 
and cerebellum discrepancies in ADHD patients.  These structures in the brain help with 
regulating attention, thoughts, emotions, behaviors and actions.7,8  Having regulation of the 
previously stated qualities, there is a plausible reason for one to consider that high rates of 
comorbidities seen in individuals with ADHD, could be due to the brain’s regulation process.  
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Studies have shown that individuals with ADHD have slower PFC maturation62 and/or reduced 
activity of the caudate, cerebellum or PFC.7  This system of the brain is sensitive to it’s 
neurochemical environment and is continuously maintained by the neurotransmitters dopamine 
and norepinephrine, using multiple receptors.7,63,64  Cortese et al.6 and Tripp et al.65 have shown a 
lower density of dopamine receptors in the brains of ADHD persons.6,65  Others researchers have 
discussed the idea of hyperactive dopamine and/or norepinephrine functioning in ADHD 
persons.64  Even with these studies, there is no conclusive evidence suggesting the cause of 
ADHD.  There seems to be a trend that either hyperactivity or underactivity of dopamine and/or 
norepinephrine receptors as potential causes to ADHD.34 
Epidemiology:  
Attention Deficit Hyperactivity Disorder is among one of the most common 
neurobehavioral/neurodevelopmental disorders affecting children between the ages 6 to 17 years 
old.1,5,66  The prevalence of ADHD ranges from 2% to 18% of the United States population.3,5,11  
This heterogeneous neuropsychiatric disorder affects 8% to 10% of school-aged children.10,38,67,68  
This number has increased with previous studies declaring this disorder affecting 4% to 10%.3,69  
The percentage of children with ADHD continues to increase, with 7.8% of children diagnosed 
in 2003, 9.5% diagnosed in 2007 and 11.0% diagnosed in 2011.9  These rates have shown to 
increase on average about 3% per year from 1997 to 2006, and an average of 5% per year from 
the years 2003 to 2011.9  
ADHD in Children:  
 In 2010 it was approximated that 2.8 to 3.9 million United States children had been 
diagnosed with ADHD.23  There is a 2:1 ratio of males to females with ADHD in their childhood 
years.1 Males are three times more likely to have ADHD than females in the general 
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population.1,2  The annual cost of a child with ADHD was determined to be $14,000 per 
child.23,70 Although ADHD is more commonly diagnosed in the younger populations, it can 
continue to show symptoms into adulthood. 11,71 
ADHD in Adolescents and Adults: 
Unlike most psychiatric disorders which are found in adulthood, ADHD is usually first 
discovered in childhood and can persist into adolescence and adulthood.38  Since this is usually a 
childhood disorder, adult ADHD is not well recognized outside of specialty clinics.72  There is a 
1.6:1 ratio males to females with ADHD in adults.1  Sixty five to eighty percent of children 
diagnosed with ADHD continue to meet the criteria for adult ADHD, even with the 
diminishment of symptoms due to maturation.34  Sixty to eighty percent of adolescents and 
adults with ADHD continue to show symptoms into their adolescent and adult years.2,10  
Meaning adolescents and adults continue to show functionally impairing symptoms as they 
continue to age.23 
It is estimated that 2.5% to 4.5% of adults in the United States have ADHD and 3.4% of 
adults worldwide.1,11,73–76  A study that followed ADHD patients, who met the full criteria for 
persistent ADHD, reported 15% of the children who followed up at age 25 continued to show 
full ADHD diagnose.77  This rate of persistence increased when the study included cases that met 
the DSM-IVs definition of ADHD partial remission, increasing to 65%.77  In a study done by 
Karam et al.78 69.8% of the participants previously diagnosed with ADHD continued to meet the 
Diagnostic and Statistical Manual for mental disorders- the 4th edition (DSM-IV) criteria for 
ADHD.78   
With age, ADHD symptoms may change.  Adolescents may not have difficulty with the 
hyperactivity aspects, but may show more concerns in regards to risky behaviors and/or time 
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management problems.  Adults with ADHD have trouble with executive functioning such as 
management of time, prioritization and completion of tasks.38  There are no known onsets of 
ADHD in adulthood.  It is common for symptoms during the childhood and adolescence years to 
go unreported, however, this tends to result from compensating efforts that are reduced or 
unavailable. 79  These symptoms are then recognized later due to adult stresses.79  There is still 
controversy on whether adult ADHD is a “real” condition.80     
ADHD: 
 ADHD is a behavior disorder that can be defined by chronic and impairing behavioral 
patterns.  These patterns cause abnormal levels of hyperactivity, inattention and/or a combination 
of both, which can lead to a disoriented lifestyle.1,2,81,82  ADHD usually results in having 
impairments with social, academic, occupational functions and hindering family functioning.1,38 
ADHD is usually associated with a lack of planning, lack of restraint, higher rates of danger, 
perceived lower health and social support and high stress levels when compared to persons 
without ADHD.75  ADHD can present in three different subtypes; predominantly inattentive 
presentation, predominantly hyperactive/impulsive presentation or a combined presentation.1,3,5   
Types of ADHD: 
Hyperactive characteristics present as restlessness, over activity, inability to wait, not 
staying seated and fidgeting.  Impulsivity is portrayed as impatience, reckless job and 
relationship changes or sensation seeking behaviors.1,10,73  Inattention presents as procrastination, 
the ability to not complete tasks, forgetfulness, disorganization and seeming as if not 
listening.1,10,73  Males tend to have more prevalence in the predominantly hyperactive or 
combined subtypes,2 while females are more likely to show predominantly inattentive 
subtypes.1,83   Females with ADHD are also more likely to suffer from eating disorders and 
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mental impairments when compared to male counterparts.83  One important aspect of diagnosing 
a patient with ADHD is the ability to differentiate ADHD from other neurodevelopmental, 
neurobehavioral as well as other possible disorders. 
 Comorbidities can make proper diagnosis of ADHD more challenging because of many 
common symptoms seen in both ADHD and in other disorders.1,34  Fifty percent of children who 
are diagnosed with ADHD simultaneously meet the criteria for defiant disorders or conduct 
disorders.  These characteristics can be seen most commonly in people with combined 
presentation of ADHD, as well as in the predominantly inattentive ADHD population.1,38  There 
is a wide range of children with ADHD, ranging from 3% to 75%, who have also been diagnosed 
with depressive disorders.84   
ADHD often presents with one or more comorbidities and other psychiatric disorders.   
Examples of comorbidities include, but are not limited to; disruptive behavior disorders, anxiety 
disorders, depressive disorders, psychotic disorders, pervasive developmental disorders, 
substance abuse disorders and learning disorders.3,5,85  These high rates of comorbidities are 
reasons it is important for clinicians to have a thorough evaluation of patients who are showing 
signs of ADHD.  If a clinician pays close attention to the differences in quality, severity and 
onset of characteristics of disorders, it can be easily differentiated between ADHD and other 
disorders with similar symptoms.73 
 Diagnosis of ADHD: 
The proper diagnosis of ADHD is important and consists of a lengthy process not only 
for the individual being diagnosed, but their family as well. A diagnosis process can be used for 
certain individuals, such as children, who are unable to undergo a full systematic assessment of 
intellectual functioning, due to their inability to complete standardized tests because of their 
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young ages.1  ADHD has often been diagnosed by pediatricians and/or other primary care 
providers rather than psychologist or psychiatrists.3  Trained clinicians primarily use the 
Diagnostic and Statistical Manual of Mental Disorders 5th edition (DSM-5) to aid in the 
diagnosis of ADHD.1,34  Only 38% of 3,900 physicians surveyed stated using the DSM-5, while 
62% of physicians make their diagnosis based solely on their clinical experience and intuition.  
This shows that physicians and primary care providers tend not to use the DSM-5 properly 
during their evaluation of ADHD.3   
The typical diagnosis process for ADHD includes rating scales that the individual must 
fill out themselves, as well as their parents, teachers and any other caregivers.  These are given to 
assess their internal behaviors to include or exclude comorbidities as well as assess external 
behaviors such as hyperactivity, impulsivity and inattention.34,79,86  These scales consist of items 
describing behavioral aspects of ADHD as well as describing the frequency of these behaviors.  
These rating scales are then compared to normal developmental aspects to see if a classification 
of ADHD is being met.79  The diagnosis depends heavily on the reports from the parents and 
teachers, as they are able to see the child’s behavior in multiple settings on a daily basis for long 
periods of times.87 
In the adult diagnosis of ADHD the use of clinical interviews, subjective reporting from 
patients and others, as well as symptom rating scales are used.88  To be diagnosed with ADHD 
the individual must present with six of the diagnostic symptoms for at least six months in one or 
both of the subtype groups to confirm a diagnosis of ADHD.  There must also be obvious 
functional impairment directly on social, academic and occupational aspects of that individuals 
life.1,5,89  There must also be an inconsistency with development levels compared to those of 
equal age.1  If a person being evaluated for ADHD is over the age of 17 years, they only need to 
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meet 5 of the diagnostic symptoms for a total of six months.1,5,34  However, according to 
previous diagnostic criteria, an individual must have had observable symptoms before the age of 
7.81  That has recently changed to patients must show observable symptoms before age 12.1   
ADHD diagnoses should be made by trained clinicians after multiple observational 
settings as well as after receiving reports form parents, teachers and caregivers or significant 
others.  This method ensures that there are no comorbities disguising as ADHD or acting 
alongside ADHD.38,90,91   Neuropsychological tests have shown to be beneficial in aiding with 
the diagnosis of ADHD in obtaining further information.  They measure visual and/or auditory 
attention and concentration, which the ADHD population shows impairments.79  These tests 
usually are performed in areas of little distraction, which could potentially minimize any 
difficulties that are commonly seen in an individual when they are in a real life setting.92  
Neuropsychological testing may be beneficial in clarifying impairments in executive 
function in adults with ADHD, but these tests alone are not yet reliable in the diagnosis of 
ADHD.93  Occasionally, computerized tests are used for measuring attention and impulsivity, 
which can be used alongside clinical evaluations of ADHD.  Unfortunately, these computerized 
measures lack sensitivity and specificity needed for diagnosis.94  Patients with ADHD are 
consistently inconsistent with both behavioral tests as well as neurocognitive tests.23  The final 
step for proper diagnosis is to have a positive response from treatment measures to confirm 
diagnosis.79 
 
 
 Management of ADHD: 
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There are a few ways that ADHD can be managed.  These treatment methods include 
drug therapy, behavioral therapy and a combination of both.34  An early and effective treatment 
has shown to have better results for the patient.  This in turn causes fewer problems as this 
disorder commonly extends into adulthood.2  The initial mechanism behind ADHD was thought 
to be bad parenting, and it was believed that behavioral treatment would be the most beneficial 
approach to treating patients.95,96  However, this technique was not a universal resolution for 
patients.34  
 Behavior management was beneficial in regards to helping adjust to difficult situations 
such as poor academic performance, peer relationships and disruptive behaviors in school or with 
the family.97,98  It has been reported that behavioral treatment along with a low dose of a 
stimulant drug was shown to be beneficial.99  Less than 1 in 3 children receive both behavioral 
therapy and drug therapy for their ADHD.9  The use of drug therapy has been seen to be more 
effective than behavioral therapy, due to the realization that this disorder was a neurochemical 
issue, rather than an effect of poor parenting.34  Treatment of ADHD symptoms with drug 
therapy was seen as being superior to behavioral therapy, but there is a positive outcome when 
both are combined.100–102   
 Drug therapy, especially stimulant treatments, are the most common and effective 
treatment methods for ADHD.34–38  The Food and Drug Administration (FDA), has approved 
multiple drugs used in drug therapy of ADHD.  These drugs include stimulants, which are the 
most popular form of treatment, and nonstimulant treatments.  Nonstimulant medications are 
considered an alternative method of drug therapy if adverse reactions occur with stimulant 
medication.  There are also off label treatments such as tricyclic antidepressants, immediate 
release alpha 2 agonists and bupropion.  These off label treatments are only used if the stimulant 
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and nonstimulant drugs show no signs of symptoms subsiding.34  Approximately 56% of people 
with ADHD are being treated by pharmacological methods, with a majority of those being 
stimulants.39 
 Simulants are seen to be helpful for 75% of the ADHD patients who use them.49  
Stimulants interact with DAT-1 and norepinephrine transporters which cause inhibition of 
reuptake of dopamine and norepinephrine.64  Two of the most common stimulants used for 
ADHD include methylphenidate and amphetamines, which are said to be equally effective.34  
Methylphenidate has quick effects, and changes in behavior are seen within 20 to 60 minutes 
after oral consumption.  The peak effects of methylphenidate occur around 90 to 180 minutes 
and the therapeutic effects tend to subside after 4-8 hours.10  Its half-life is between 2 to 7 hours 
and is metabolized by the liver.10  Methylphenidate is said to be preferred over amphetamines 
due to its slower uptake and clearance, which makes it less likely to cause dependence and 
physical harm.55   
There is controversy on the use of amphetamines and methylphenidate due to the fact that 
they are ranked as the 6th and 12th substances respectively to cause physical harm and the 8th and 
13th substances respectively for dependence.55  In a survey of adolescents and adults, 25% 
admitted to abusing or altering the use of their stimulant drugs.34  College students nationwide 
were surveyed and 4% stated using Ritalin at least once without a prescription in 2006.103  While, 
in 2008 5.3% of college students admitted to using stimulants for nonmedical reasons.104  The 
use and abuse of stimulant medication has increased, and physicians should be aware of the signs 
of inappropriate use of ADHD medication, especially among athletes.79   
There are concerns of the use of stimulant medication in many aspects of life.  For 
children who have received stimulant medication, 75% showed drastic improvements in 
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behavior, academic performance, cognitive performance and socialization.40  There are concerns 
about stimulant medication giving ADHD patients unfair advantages in areas of academics, as 
well as occupational performance when compared to normal counter partners.34  With these seen 
advantages there are also some disadvantages to this medication that should be considered.   
 Stimulant medication may be the more common drug therapy, but may not be suitable for 
up to 30% of the ADHD population.105,106  Stimulant medication is prescribed to over 1 million 
school aged children.107  Every patient has a different response to their medication, which can 
cause physicians to use a trial and error method to determine appropriate dosage.  Doses are 
increased slowly every 1 to 3 weeks from the starting does, which is based off body weight until 
the proper dose to reduce symptoms is met.108–110  This method tends to be trial and error and 
based off clinicians previous experiences.  With these stimulant drugs there are also hazardous 
side effects.   
Side effects of stimulant drugs include; insomnia, anorexia, abdominal pain, weight loss, 
headache, irritability, emotional ability, anxiety, increased blood pressure, dry mouth, nausea, 
vomiting, diarrhea, and tics.34,111,112  Adverse effects can last up to 24 hours initially, but the 
severity of these effects tend to diminish after the first two weeks of consumption.10  
Contraindications for the use of stimulant medication include persons with hypertension, 
glaucoma, hyperthyroidism, symptomatic cardiovascular disease, structural heart disease, 
psychosis, stimulant hypersensitivity, history of drug dependence, and associated use of 
monoamine oxidase (MAO) inhibitor.113  For patients who do not see improvement of symptoms 
with stimulant medication there are multiple drug therapy options available.    
   The second option of medication for ADHD individuals is nonstimulant medication.  
This is usually given when stimulant drugs are nonresponsive and/or when the adverse side 
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effects worsen symptoms or cause more concerns, as well as based on family history and family 
preference on medication.34  Nonstimulants increase the availability of both norepinephrine and 
dopamine in the synapse of the PFC, which is thought to improve the function of the PFC in 
persons with ADHD.114,115  Nonstimulant medication was approve by the FDA for the treatment 
of ADHD in 200334,38 and can last up to 24 hours.38  Unfortunately, due to lack of initial effects, 
some nonstimulants medication require 4 to 6 weeks to show full effect of medication.116  Like 
stimulants and any other oral medication, nonstimulants also have adverse side effects.  These 
side effects include decreased appetite, nausea, vomiting, fatigue, insomnia, abdominal pain, 
increased sweating, dry mouth, hepatotoxicity, constipation, somnolence, urinary retention, 
dysuria, erectile dysfunction and dysmenorrhea.34,79  With many treatment options for ADHD, 
inadequate treatment is common and continues to be an issue in the ADHD population.117  
Treatment guidelines are not well established causing clinicians to rely heavily on clinical 
experiences, as well as the patient’s response to medication and parents observations upon 
starting medication.34   
ADHD in Athletes: 
The adult ADHD controversy is further complicated with the debate regarding ADHD in 
athletes.  ADHD in athletes has been shown to cause cognitive impairment which has been seen 
to affect motor coordination along with sequencing, anticipation, and planning.10  Other common 
traits seen in athletes with ADHD include poor attention span, difficulty initiating or completing 
tasks, especially when they are not engaged, difficulty waiting, increased risky behavior, 
inability to manage time, and trouble with organization skills.38   
Speculations exist regarding the effects of ADHD medication, especially stimulants, on 
an athlete’s ability to participate in sports.38  Some athletes have started taking their medication 
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with the mindset that they will have improved sports performance while on their stimulant 
medication.  Other athletes may stop taking their medication in hopes that their unfocused mind 
and unpredictable qualities will improve their performance.41  Side effects of stimulant 
medication that can negatively affect the athlete’s performance include suppressed appetite, 
causing the athlete not to gain weight if needed, as well as delayed growth.112   
Medication Restrictions for Athletes with ADHD:  
Knowledge of medication is important in the collegiate setting due to strict National 
Collegiate Athletic Association (NCAA) regulations.  In the collegiate setting, if an athlete is 
prescribed a stimulant drug for the treatment of ADHD, the NCAA requires certain 
documentation.   This documentation must include, at a minimum, a description of the evaluation 
process, including assessment tools used and the procedures performed to arrive at the diagnosis. 
A statement of the exact diagnosis, history of ADHD treatment, a statement from a physician 
that non-banned alternatives were considered, which include non-stimulants and counseling, as 
well as documented follow ups monitoring vitals.38,79,88  The athlete must also have annual 
evaluations and report their condition to the medical staff and athletics department 
immediately.38,79,88  Stimulants used by athletes are banned during competition in all World Anti-
Doping Agency (WADA)38,79, United States Anti-Doping Agency (USADA),38 and International 
Olympic Committee (IOC) events.79  It is necessary for physicians who work with athletes at all 
levels to know and understand rules and regulations for medications athletes are taking.     
   
 
General Reaction Time:  
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 When looking at fine and gross motor skills, an important aspect to consider is reaction 
time.  Reaction time has been defined as the time it takes to initiate a response after a sensory 
stimulus has been brought about.17  Simple reaction is a task in which an individual performs the 
same response to a single stimulus every trial.18–20  Complex reaction involves more than one 
stimuli and/or response across different trials.18 
An accepted number for mean simple reaction time in college aged people has been 
reported as approximately 190ms for light stimuli and 160ms for sound stimuli.20,118  Visual 
stimuli takes about 20-40ms to reach the brain,119 causing visual reaction times to range from 
180-200ms.20,118  The fastest reaction times arise when a stimulus is seen by the cones of the eye, 
meaning the person was looking right at the stimuli.  When the stimulus was detected by the 
rods, or around the edge of the eye, the reaction was seen to be slower.120  Ando et al.121 found 
that, when practiced, reaction time to a visual stimuli in the central vision area is shortened, as 
well as with practice the reaction time to a stimulus in peripheral vision is also shortened.121 
Comparing ADHD to Non-ADHD:  
 There are noticeable differences between people with and without ADHD.  People with 
ADHD have shown cognitive impairments and skills that fall outside of normal ranges.  These 
include executive functions, such as memory, information processing speed and basic motor 
functions.57,58  Executive function refers to a set of cognitive processes that enable a person to 
deal with uniqueness, select strategies to solve problems, inhibit inappropriate responses, 
monitor performance and adjust behaviors to achieve goals.73  Problems with motor 
coordination, sequencing, working memory, mental computation, planning, anticipation and 
many others are commonly seen.12  
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It has been regularly cited that children and adolescents with ADHD commonly have 
poor coordination, poor balance and poor motor ability.13–16  One of the major problems in 
adulthood ADHD is inattention and executive dysfunction,1,73,122,123 issues with time 
management, prioritization, and task completion.38  These traits are usually associated with adult 
ADHD due to the higher cognitive demands.122  Common traits seen in athletes with ADHD who 
don’t receive medication are poor attention spans, difficulty initiating tasks that are boring and 
not engaging, too much attention to a novel situation, difficulty waiting one’s turn, increased 
risky behaviors, inability to manage own time, difficulties with unstructured time and lack of 
organization skills.79  There is little research on the physical fitness and gross motor skills in 
children with ADHD.15 
Movement Skills in ADHD: 
Movement skills are necessary in a person’s ability to perform sport specific activities, as 
well as have functional involvement in physical activity.124  Research has suggested that children 
with ADHD may be at a higher risk for movement skill difficulties.16  Patients with ADHD may 
be at risk for developmental delays in fundamental movement skill performances compared to 
peers.16  Children with ADHD have demonstrated not performing well with movement related 
activities, but this has still not fully been proven.125  When looking at children with ADHD in 
terms of fitness and fundamental gross motor skills, they tended to be below average when 
compared to normal matched individuals.15   It is observed that older children have better 
fundamental movement skills than younger children.16  With deficits in movement being seen in 
children with ADHD, within activities of daily living, this could cause concerns about that 
person’s ability to play sports.   
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Reaction time Variability in ADHD: 
Individuals with ADHD show increased reaction time variability (RTV) across a large 
range of tasks including measuring reaction time motor speed, choice decision, vigilance, 
behavioral inhibition, cognitive interference, working memory, visual saccade, and visual 
discrimination.24–27  Reaction time variability is attributed to periodic lapses of attention.  These 
occur randomly and periodically, causing slower responses in ADHD persons.23,28–30  Reaction 
time variability can be described as an inconsistency in a person’s responding speed, which is 
measured in seconds or milliseconds.26  Another term commonly used in research regarding 
reaction time variability in ADHD patients is intra-individual variability.   
Intra-individual variability refers to the moment-to-moment (within a subject) 
fluctuations in behaviors and task performances occurring over shorter periods of time rather 
than hours or days.31,126  Long reaction times are seen to be a part of similar cognitive process 
that surround omission errors.31  Omission errors occur when the participant does not respond to 
a target stimuli.127  This inability to respond could be due to the lapse in attention requiring 
longer reaction times.31  Children with ADHD experience impaired senses of time, implying they 
may get caught up in the moment.87  When performing computerized tests, errors of inattention 
(omission errors), an inconsistency of reaction time, are seen to occur regularly with ADHD-
inattentive type.38  Longer reaction times have been noticed in children before an omission error 
occurs, as well as slowing motions after an omission error occurs.31  RTV appears to be 
characterized as a single factor in children with ADHD, which could suggest a stable 
characteristic in ADHD patients despite large differences in task demands.26 
Research in the past 8 years has shown reaction time variability could be a feature of 
ADHD patients.23  Reaction time distributions tend to be positively skewed especially for 
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individuals with ADHD resulting in abnormally slower responses.23  Willcutt et al.27 has shown a 
moderate to large magnitude d=0.71 in ADHD patients in regards to intra-individual variability 
compared to variability of normally developing children.27  Kofler et al.23 performed a meta-
analysis and found that ADHD-combined type were significantly more variable when compared 
to ADHD-inattention and ADHD-hyperactive.23  Harvey et al.16 used the TGMD-2 to look at 12 
movement skills.  The TGMD-2 is commonly used in physical education departments to test and 
assess 6 locomotive skills (run, gallop, hop, leap, horizontal jump and slide) as well as 6 
objective control skills (striking a stationary ball, stationary dribble, catch, kick, overhand throw 
and underhand roll).  It was noticed that children with ADHD scored worse than peers without 
ADHD in both the placebo and medication trials.16   
Bedard et al.123 looked at the ability to inhibit inappropriate motor responses and to 
ignore irrelevant stimuli in the ADHD population.123  This study indicated that ADHD children 
had a greater proportion of invalid trials when compared to normally developed counter 
partners.123  Children with ADHD showed a larger proportion of invalid trials when compared to 
that of non ADHD participants.  Using 5 computer tasks, ADHD participants were less accurate 
(p=0.004), more variable (p=0.01) and slower (p=0.004).123  Reaction time variability may 
normalize after the effects of taking stimulant medication are established.126,128,129  
Once a stimulant medication has been used, there is a rapid and predictable decrease in 
disruptive symptoms and an increase in attentiveness shown.32  Benefits of stimulants include 
attention and concentration improvements as well as fine motor coordination and balance.10  
Stimulant medications may enhance task efficiency rather than achievement outcomes.16  
Methylphenidates/stimulants were associated with large decreases in RTV, while nonstimulant 
medication treatment did not change RTV significantly in ADHD individuals.23  Since no 
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significant changes were found in the nonstimulant category they were viewed as ineffective for 
these patients.23  A study demonstrated that patients with ADHD had significantly improved or 
normalized RTV when medicated with their medication.23  
Stimulant medications has demonstrated a large magnitude effect on RTV for individuals 
with ADHD, indicating that about 45% of individuals scored outside of their pretreatment range 
after taking a stimulant medication.  Harvey et al.16 showed no significance between or within 
the effects of the medication on purely movement skills performed in boys with ADHD.16   
Although the data states mixed outcomes on the effects of stimulant medication on participants 
with ADHD, it is thought that athletes with ADHD may be perceived as having an unfair 
advantage in competition.16   
 There are certainly concerns for athletes who are on stimulant medication that team 
physicians and sports medicine staffs should be aware.  First, stimulant medication has the  
potential for abuse by ADHD patients.79  ADHD patients who consume stimulant medication 
have increased core temperatures and may have a higher risk for heat illness.79  Methylphenidate 
can elevate the heart rate, initially by 11 beats per minute for patients who are new to the 
stimulant and elevate 4 beats per minute for individuals who have been on the medication for an 
extended period of time.130  It is also common for stimulant medications to increase blood 
pressure in athletes.131,132  In the adult population stimulants have shown to increase blood 
pressure by 4mmHg.73  With these commonly seen issues the American Heart Association 
suggests that physicians continuously monitor athletes blood pressure and heart rates while the 
athletes continue to take stimulant medication.79  While there are some disadvantages of adult 
ADHD, there are recorded benefits for stimulant medication.   
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Fine motor coordination and balance are shown to improve after the administration of 
methylphenidate.13,50  Stimulant medication improved not only fine motor skills, but reaction 
times in ADHD participants.50,51  The improvements seen in concentration and attention are 
considered beneficial in sports.133  Chandler et al.134noticed that amphetamines were able to 
significantly improve acceleration of ADHD individuals.134  When observing students in college 
without ADHD, no increases in strength, power, nor speed were seen, but improvements in 
acceleration with the use of amphetamines in non-ADHD individuals was observed.134  
Methylphenidate at the dose of 0.3 mg/kg and 0.6 mg/kg showed to have a positive effect on 
attention span during games.16,38  Five out of nine people previously diagnosed with ADHD, who 
were taking Ritalin, showed improved skills while on medication.16  A study found that 77% of 
its subjects performed better on amphetamines, while 59% stated having only subjective 
helpfulness of the drug.38  Subjective enhancements in performance may include sense of 
euphoria, improved concentration and increased aggression along with a decrease in reporting 
pain.135  Methylphenidate, modafinil and bupropion have been seen to have the ability to mask 
symptoms of fatigue especially in areas of warm climate.136  As a general statement, athletic 
individuals who are given a stimulant medication noticed an improvement in sports performance.  
They did see effects vary for each individual and the nature of the sport they participated in.10  
Athletes who choose stimulant treatment may be able to focus better on a task and be more 
aware of positions and time in sports.38 
Reaction time assessment tools:  
 The Ruler Drop test (drop test) is a clinical tool that measures reaction time and 
movement time.137  The Ruler Drop test is a simple clinical standardized visuomotor reaction 
time test made of an 83cm long measuring stick covered with high friction tape, marked in 0.5 
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cm increments, which is then embedded into a hockey puck.137–139  Participants are seated with 
their dominant forearm resting on the table and the hand extending off the edge of the table.  The 
administrator of the exam suspends the drop stick so that the puck is in the space between the 
open hand and not touching any part of the hand.  The instructor then releases the stick within a 
2-5 second window; and then the participant is instructed to catch the device as quickly as 
possible.  The placement of the hand on the stick after catching it is then used to measure the 
reaction time.  When the post injury reaction time is slower than the baseline reaction test, it is 
presumed to be an abnormal test.18,137,139  
 The drop test is currently used in concussion assessment for reaction time.  The drop test 
has been recognized in the literature to have a sensitivity of 75% and a specificity of 68% in 
regards to assessing sports related concussions in athletes, with a confidence level of 65%.18,137  
Eckner et al.18 reported inter-rater reliabilities for simple reaction time latency measures 
clinically using the drop test to be 0.74.18  Latency was described as the time interval between 
the start of the device accelerating to the start of the device decelerating, the difference between 
these two numbers are used to find reaction time using this method.18  Intraclass correlation 
coefficient (ICC) is used to determine ideal and preferred clinical decision making in regards to 
techniques that should be used.139  The ICC rates for simple reaction time range from 0.608139 to 
0.76.18   
Age has been shown to be a contributing factor to the reliability of simple clinical 
reaction time (RTclin).  ICC for high school to college range from 0.645140 and 0.68.139  Age 
differences have suggested that there is a positive correlation between simple RTclin and age, 
with the drop test presenting faster reaction times in the collegiate setting.139  A practice effect 
was seen in healthy individuals as their reaction times improved after repeating the tasks.137  It 
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was thought that the practice effect averaged an improvement of 2.4ms per trial, but was not 
significant.138   
Reaction time has shown to steadily plateau after the first trial, this information should 
encourage clinicians to allow for at least one practice session before the start of baseline or data 
collection.137  Unfortunately, there is no known research on the drop test in individuals with 
ADHD, without a previous history of a head injury.   
 Another useful tool that can be used to assess and measure reaction time is the 
Dynavision D2 Visuomotor training device.44  In an athletic population the Dynavision can be 
used to improve reaction time, peripheral visual awareness and decision making under stress.141  
The Dynavision has a training surface that consists of small buttons that illuminate, which form a 
pattern of five rings around each other.  As the lights illuminate the participant is to hit the 
illuminated button.  Once it has correctly been selected a beep will signal a successful hit, then 
the light will move to another random location on the board and that will continue till the end of 
the test.  The device records the total number of hits during the various conditions and are 
recorded.43  There are mixed reports of ICC ranges, with studies ICC’s ranging from 0.88 to 
0.9743  to 0.73 to 0.84.44  
 There are different settings that can be used with the Dynavision.  Mode A, which is one 
of the more commonly used programs, begins with a 5 second countdown to start the trial.  The 
board then lights up and the participant is supposed to strike the stimulus.  Once the light is hit it 
randomly moves to another section of the board.  This continues for 60 seconds, the participant is 
encouraged to hit as many of the lights has possible with both hands in the allotted amount of 
time.44  This showed significance between trial 1 and trial 2 (p=0.001).44  There is a notable 
learning effect seen in the Mode A technique.44  Some literature has stated that the Dynavision 
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does not show a practice effect after three trials.43,44(48, 50, 51,59)  Dynavision showed to have a 
strong visual reaction time ICC 0.84 and a moderate motor reaction time reliability ICC of 
0.63.44 
 Another setting that can be used is Mode D.  During this setting the participant holds an 
illuminated home button with their dominant hand to start the trial.  A button in a different 
section from any of the four locations will light up adjacent to the home button on the same 
horizontal plane, in a circular pattern, as well as a direct stimuli.  Once the participant recognizes 
the stimuli they leave the home button, then hit the new button that is illuminated.  The 
participant is then required to return back to the home button to proceed with the next trial.44  
The Mode D setting has the ability to measures a participant’s visual and motor reaction time.   
Visual reaction time for the CRT showed strong reliability having an ICC ranging from 
0.73-0.84. 44,142  The motor reaction time had a moderate reliability, having an ICC of 0.63.44  
There were no significant differences between the consecutive sessions when using this test 
program, indicating there was no learning curve present.  This absence of a learning curve could 
be due to lack of task complexity with this program.42  
 A third program that can be used is the Simple Visual Reaction Test (SRVT).  This test 
requires the participant to hold down one button with their dominant hand and then must hit 
another key that is 30cm away when a new light occurs as quickly as possible.  This test program 
allows the researcher to simultaneously look at visual reaction time and movement time. 43  
There are no known validity or reliability data available for the SVRT setting.   
One study looked at lingering deficits following a concussion by assessing visual motor 
skills using the SVRT Dynavision setting.143  When that study compared controls to concussed 
individuals no interaction was found between session or group for either reaction time or 
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movement time.143  In this study reaction time was considered the amount of time required for 
the central nervous system (CNS) to perceive the stimulus and then decide upon and initiate a 
motor response.143–145  This study found improvement in reaction time for both groups, which 
could indicate an increased speed in the CNS planning.144   
Testing Concerns:  
An important concept to take into consideration with ADHD individuals, especially with 
testing, is their interest and motivation.  People with ADHD often have difficulty with initiation 
or completion of tasks and activities when they find them boring or unengaging.38  If an ADHD 
individual finds an activity to be more interesting it is more likely they will perform that task 
more efficiently.38  Motivation may potentially play a big role in the skill difficulties experienced 
by children with ADHD.16  That is why it is important for a child, especially an athletic child 
with ADHD, to want to participate in sports that they are interested in and motivated to do, so 
they do not continue to be at a higher risk for movement issues and inattention.   
With testing, another important concept to consider is effort.  When testing participants, it 
is sometimes unclear to the examiner whether maximum effort is being performed during 
baseline testing.146  In the past, effort has sometimes been estimated by examiners based on 
subjective clinical impressions.147  Poor effort can be associated with impaired test performance 
showing lower than normal ranges when compared to people with symptoms and organic 
disorders.146   
When dealing with medical disabilities examiners need to be aware that test scores may 
be invalid due to sub-optimal effort.147  Hunt et. al146 came to the conclusion that one out of 
every ten athletes showed poor effort during baseline testing.146  Green et al.147 found in his study 
that effort explained 53% of the variance in neuropsychological test data.147  Significant 
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differences are seen between athletes with poor effort and adequate effort with 
neuropsychological testing.146  Participants who showed poor effort performed worse on tests 
measuring information processing, memory, attention/concentration, learning and gross motor 
speed when compared to an adequate effort group.146  These traits could be of concern for the 
ADHD population and their effort towards testing.    
Conclusion 
In conclusion, attention deficit hyperactivity disorder is a neurodevelopmental/ 
neurobehavioral disorder that is very prevalent.1,5,66  ADHD in athletes has been shown to cause 
cognitive impairment which can affect motor coordination along with sequencing, anticipation 
and planning.10  Other common traits seen in athletes with ADHD include; poor attention span, 
difficulty initiating or completing tasks, especially when they are not engaged, difficulty waiting, 
increased risky behavior, inability to manage time, and trouble with organization skills.38  The 
common symptoms seen in patients with ADHD will likely affect their sports performances.  
Altered sport performance in athletes with ADHD can be due to variability in reaction time.  The 
ability to react while concurrently processing and integrating visual cues in an environment that 
is continuously changing are key components to being successful in sports.44  With studies 
demonstrating lack of fitness and fundamental gross motor skills,15 it is understood that persons 
with ADHD may not perform to the same levels of their normally developed peers.  
Unfortunately, there is little research on the physical fitness and gross motor skills in the athletic 
population of persons with ADHD.15  
Stimulant treatments are the most common and effective treatment methods for people 
diagnosed with ADHD.34–38  Stimulant medication has shown to help improve sports 
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performance.10  With this seen increased performance, ADHD medication continues to be a topic 
of controversy.   
There is still a need for assessments of movement skills of athletes with and without 
ADHD, as well as discover the effects of stimulant medication on overall fundamental 
movement.16  With little research done in this area, the purpose of this study was to determine 
the effects of stimulant medication on reaction time, in recreationally active individuals with and 
without self-reported Attention Deficit Hyperactivity Disorder (ADHD). 
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Personnel: 
 The research team includes: Nichole LaFortune, ATC-Graduate Student/Primary Investigator, 
Dr. Tamerah Hunt, PhD – Georgia Southern Faculty Member/Co-Investigator (CHAIR) has 
experience working with the ADHD population with concussion research, Dr. George Shaver, 
Psy. D-– Georgia Southern Faculty Member/Co-Investigator has experience working directly 
with learning disorders such as ADHD and Dr. Barry Munkasey, PhD– Georgia Southern 
Faculty Member/Co-Investigator has experience working in with biomechanical devices such as 
the Dynavision, which will be used in this study.    
 
Purpose: 
The purpose of this study was to determine the effects of stimulant medication on reaction time, 
in recreationally active individuals with and without self-reported Attention Deficit 
Hyperactivity Disorder (ADHD). 
 Research questions: 1) Does reaction time differ between ADHD participants off medication 
compared to controls?  2) Does reaction time differ between ADHD participants on medication 
compared to controls? 3) Does reaction time differ between ADHD participants on medication 
verses off medication? Hypotheses: 1) ADHD participants off their medication will have slower 
reaction times compared to that of controls.  2) ADHD participants on their medication will have 
comparable or better reaction times compared to that of controls.  3) ADHD participants on their 
medication will have better reaction times than when they are off their medication.   
 
 
Literature Review.   
 Attention Deficit Hyperactivity Disorder (ADHD) is a neurodevelopmental/ 
neurobehavioral disorder defined by chronic and impaired behavior patterns that cause abnormal 
levels of  attention and focus, hyperactivity, impulsivity, and disorganization.1–4  There continues 
to be no known cause of ADHD, there are several hypotheses addressing the physiological 
aspects of this disorder.  These hypotheses range from reduced volume and functionality of gray 
and white matter in the brain6 to reduced function of the prefrontal cortex (PFC), caudate and 
cerebellum in ADHD patients.7,8   
The ADHD population warrants focus as the rates of diagnosis increase every year.  In 
2003, 7.8% of children in the U.S. were diagnosed with ADHD, then in 2007, 9.5% of children 
were diagnosed, and in 2011, 11.0% were diagnosed.9  The diagnosis rates have increased on 
average about 3% per year from the years 1997 to 2006 and an average of 5% per year from the 
years 2003 to 2011.9  Unlike most psychiatric disorders that are discovered in adulthood, ADHD 
is first diagnosed as a child and can persist into adolescences and adulthood.4  As high as 60% to 
80% of ADHD individuals continue to show symptoms into their adolescent and adult years.2,10  
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It is estimated that 2.5% to 4.5% of adults in the United States have ADHD and 3.4% of adults 
worldwide.1,11  With high rates of ADHD people in the population it is important to understand 
the differences between people with ADHD and people without ADHD.     
There are noticeable differences between people with ADHD and without ADHD and an 
important difference appears in motor performance.12  It has been regularly cited that children 
and adolescents with ADHD commonly have poor coordination, poor balance, and poor motor 
ability.13–16  These components of motor performance and coordination that are commonly seen 
as worse in the ADHD population are necessary components within participating in physical 
activity.  Unfortunately, there is little research in the physically active population with ADHD in 
regards to physical fitness and gross motor skills in the adult population.15  
 
Movement skills are necessary in a person’s ability to perform physical activities well, 
including the ability to functionally move during sport activities.124  Research has suggested that 
children with ADHD may be at a higher risk for movement skill difficulties.16  When looking at 
children with ADHD in terms of fitness and fundamental gross motor skills, they tended to be 
below average when compared to normal matched individuals.15   With deficits seen in children 
with ADHD regarding movement patterns, it can be assumed that these children who progress to 
have ADHD as adults who are physically active, could demonstrate these deficits in their ability 
to participate in sport and physical activities.   
 
Potential movement deficits in physically active people with ADHD can be deduced that 
reaction time would be affected.  Reaction time can be defined as the time it takes to initiate a 
response after a sensory stimulus has been brought about.17  Individuals with ADHD show 
increased reaction time variability (RTV) across a large range of tasks including measuring 
reaction time motor speed, choice decision, vigilance, behavioral inhibition, cognitive 
interference, working memory, visual saccade and visual discrimination.24–27   
 
RTV can be described as an inconsistency in a person’s responding speed, which is 
measured in seconds or milliseconds.24–27  RTV is attributed to periodic lapses of attention, these 
occur randomly and periodically, causing slower responses in ADHD persons.23,28–30  When 
performing computerized tests, errors of inattention (omission errors), an inconsistency of 
reaction time, are seen to occur regularly in people with ADHD especially ADHD-inattentive 
type .38  With the use of stimulant medication, some of these deficits have shown improvements.   
  
 ADHD is a very controversial topic, especially in regards to people who participate in 
physical activity.  People with ADHD have shown to have cognitive impairments. 10  These 
impairments can affect motor coordination, sequencing, anticipation, and planning.10  The 
predisposing disadvantages seen in the ADHD population can affect a person’s everyday life.  It 
is just as likely to have an effect the performance levels of physically active individuals during 
physical activity.  Specifically, athletes with ADHD has become a major controversial topic due 
to the fact that there are speculations in regards to the unknown effects of ADHD medication, 
especially stimulant medication on a person’s ability to participate in sports or physical activity.4   
 
 Drug therapy, especially stimulant treatments, are the most common and effective 
treatment and management of ADHD.34–38  Approximately 56% of people with ADHD are being 
treated by pharmacological methods, specifically stimulant medication.39  Each of the medication 
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has different peak effects, half-life, and patient reactions.  There are concerns about stimulant 
medication, and their advantages for ADHD patients compared to non ADHD population.34  
 
One study showed that when prescribed a stimulant medication, there was a 75% 
improvement in behavior, academic performance, cognitive performance and socialization 
seen.40  Some who take stimulant medication have admitted to having a mindset that the 
medication will help improve their performance with cognition and physicality.41  The use and 
abuse of stimulant medication has increased and physicians should be aware of the signs of 
inappropriate use of ADHD medication, especially among athletes.79  
 
Once a stimulant medication has been used, there is a rapid and predictable decrease in 
disruptive symptoms and an increase in attentiveness shown.32  Benefits of stimulants include 
attention and concentration improvements, as well as fine motor coordination and balance 
improvements.10  Stimulant medications may have the ability to enhance task efficiency.16  
Stimulants have been associated with large decreases in RTV, showing that patients with ADHD 
significantly improve or normalized RTV. 23  Although there are mixed sources stating the 
effects of the medication, some elite athletes with ADHD are perceived as having an unfair 
advantage in competition.16  This perceived idea leads to the topic of do stimulant medications 
give people with ADHD an advantage in performing physical activities. 
 
There is still a need for assessments of movement skills of physically active individuals with and 
without ADHD as well as the effects of stimulant medication on fundamental movement.16  The 
purpose of this study was to determine the effects of stimulant medication on reaction time, in 
recreationally active individuals with and without self-reported Attention Deficit Hyperactivity 
Disorder (ADHD). 
 
 
Outcome.  The results of this study will show no immediate benefits for the participants.  These 
results may show the differences in reaction time in the ADHD population while on and off their 
medication.  These outcomes will provide an initial understanding of the effects of commonly 
used medication used in this population.  Further, these results can provide an initial 
understanding of how ADHD medications may influence reaction time in commonly utilized 
concussion assessment tool for athletes.     
 
Describe your subjects:  Participants will be taken from a convenience sample of recreationally 
active college students.  These participants will be divided into two groups; a control group and a 
group of self-reported diagnosis of Attention Deficit Hyperactivity Disorder (ADHD).  We 
expect to have a total of 34 participants, 21 controls and 13 self-reported ADHD patients. 
Inclusion criteria for self-reported ADHD participants: must be between the ages 18-25 years 
old, males and females who have a self-reported ADHD diagnosis with prescribed stimulant 
medication and must be recreationally active.  The inclusion criteria for the control group: must 
be between the ages of 18-25 years old, must be recreationally active and must not have a 
diagnosis of ADHD.  Recreationally active is being defined as participating in some form of 
physical activity for 20 min three times per week.60  The exclusion criteria for both groups 
includes: no musculoskeletal or head injury in the last 6 months, patients with prescribed non-
stimulant medication, mental health comorbidities, such as anxiety or depression, no other 
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prescribed medications for comorbidities, must not smoke, no use of alcohol or within 24 hours 
of testing, and individuals that continuously and regularly take their medication.  
 
Recruitment and Incentives: The participants in this study will do so voluntarily.  A paper flyer 
will be used for participant recruitment.  The flyer will be posted in the university’s Recreation 
Activity Center building as well as in the Hollis building.  An incentive will be used to help with 
recruitment.  All participants who complete both trials will have their ID numbers placed in a 
drawing for one $50 Visa gift card.   
 
Research Procedures and Timeline:  
Following IRB approval, flyers will be hung Hanner, Hollis, the SDRC, and the student health 
center.  Prior to participant enrollment, ADHD participants will be contacted by the researcher to 
discuss their normal medication regiment.  These normal medicine regiments will be used to 
determine when scheduling the off medication test session will be completed.  Participants will 
be provided with an informed consent form as well as a demographics sheet prior to testing.  For 
both groups, each person will be assigned an ID number for confidentiality purposes.  Only the 
researcher will have access to the decoding of the ID numbers.  The key to the ID numbers will 
be locked on a password protected computer.  Each individual will come into either the 
biomechanics lab or the RAC and perform two Dynavision testing programs. 
The participants will arrive during their specified test date and time to complete tests 
Mode A and Mode D. This testing will last approximately 20 minutes per test session, requiring 
two separate test sessions. A follow-up appointment for retesting will be made within the next 
48-72 hours.  Once all of the data is collected the information will be input into IBM SPSS 
Statistics 23 software (SPSS Inc, Chicago, IL).   
 
 
Data Analysis:   
This is a prospective pre-post study.  The independent variables for this study are the 
groups (ADHD and Controls) and the testing session (on medication verses off medication).  The 
dependent variables are reaction time outcomes of the individual tests as well as reaction time 
variability.  Statistical analysis will be calculated using IBM SPSS Statistics 23 software (SPSS 
Inc, Chicago, IL).  Statistical assumptions that are accounted for are sphericity, independency of 
cases, normality, and variance of equality or homogeneity.  This study will use a 2 (group) x 
2(time) mixed model repeated measures analysis of variance (ANOVA).  A paired-sample t-test 
was run do compare ADHD participants on medication to off medication.  This test will look at 
reaction time of the ADHD population on their medication while off their medication and then 
compare that to controls.  The alpha level will be set a priori at 0.05.  The effect size will be 
calculated using the partial eta squared.  The researcher will also manually calculate the reaction 
time variability (RTV) of the physical reaction time, during Mode D and use the average reaction 
time over the 3 practice trials and 5 test trials of Mode A.  Prior to calculations the researcher 
will examine normality, outliers and assumptions. 
 
 
Special Conditions: 
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Risk:  The participants may be at risk of experiencing discomfort in identifying as having 
ADHD.  There may be a negative stigma associated with the diagnosis of ADHD. However, this 
risk will be mitigated by utilizing ID codes as well as password protected computer for data 
storage. 
 
 
Research involving minors: This research study does not involve minors.  
  
Deception.  This study does not involve deception.   
 
Medical procedures.  This study does not involve medical procedures.  
 
Cover page checklist.  
Informed consent was checked on the cover page and has been described in the procedures 
section of the narrative.   
 
Reminder:  No research can be undertaken until your proposal h 
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INFORMED CONSENT TO ACT AS A SUBJECT IN AN EXPERIMENTAL STUDY  
 
Title of Project: Effects of Stimulant Medication on Reaction Time in Recreationally Active 
Individuals with Attention Deficit Hyperactivity Disorder 
 
Investigator’s Name: Nichole LaFortune, ATC       Phone: (804)-381-9767 
 
Participant’s Name: ________________________      Date:________________ 
 
Data Collection Location: Hanner Biomechanics Lab, Georgia Southern University 
 
1. My name is Nichole LaFortune and I am an Athletic Training Graduate Assistant at 
Georgia Southern University.  I am doing this research as a requirement to complete my 
Master’s program at Georgia Southern University.   
 
2. The purpose of this study was to determine the effects of stimulant medication on 
reaction time, in recreationally active individuals with and without self-reported 
Attention Deficit Hyperactivity Disorder (ADHD).     
 
3. Participants in this study with be divided into two groups, the control group and the self-
reported ADHD group.  Each participant will be assigned an ID number for 
confidentiality purposes.  Participants will be provided with a consent form as well as a 
demographics sheet prior to testing.  Each individual will come into the biomechanics lab 
and perform two Dynavision testing programs.  Participants will perform the Choice 
Reaction Test (CRT) also known as Mode D as well as the Simple Visual Reaction Test 
(SVRT) also referred to as Mode A. They will also answer a post-test effort scale after 
the completion of their testing.  A follow-up appointment for retesting will be made 
within the next 48-72 hours. Participants will be expected to complete two sessions that 
will last approximately 20 minutes each.  
   
4. There is minimal risk involved in the study. The participants may be at risk of experiencing 
discomfort in identifying as having ADHD.  There may be a negative stigma associated with the 
diagnosis of ADHD. However, this risk will be mitigated by utilizing ID codes as well as 
password protected computer for data storage.  If at any time, the participant feels 
uncomfortable or wish to withdraw from the study they may do so. Additional materials 
can be provided to the participants with information to seek counseling if necessary.     
  
5. There are no direct benefits to you as the participant.  There may be benefits regarding 
future research, care and outcome of future athletes with ADHD.  These benefits may 
include understanding the impact of commonly prescribed medication on concussion 
assessment tools.  This research could also lead to additional research on ADHD athletes 
in sports and how medication affect their performance. 
 
6. The duration of the study will be approximately 20 minutes per session for two sessions 
with the completion of all testing taking approximately 40 minutes.   
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7. You will not be identified by name in the data set or in any of the reports using 
information obtained from this study. Your confidentiality as a participant in this study 
will remain secure.  An ID number will be given to you during this study for 
confidentiality purposes.  Only the researcher will have access to the decoding of the ID 
numbers.  Subsequent uses of records and data will be subject to standard data use 
policies which protect the anonymity of individuals and institutions. All information 
obtained will be stored on a secure computer that is password protected.  After the data is 
collected and analyzed it will be kept in a secure location for a minimum of three years 
following the completion of the study.    
 
8. You have the right to ask questions and have those questions answered.  If you have 
questions about the study, please contact the researcher named above or the researcher’s 
faculty advisor, whose contact information is located at the end of the informed consent.  
For questions concerning your rights as a research participant, contact Georgia Southern 
University Office of Research Services and Sponsored Programs at 912-478-0843. 
 
 
9. You will not receive any form of compensation for participation in this study.  There will 
be a $50 gift card that your ID number will be placed into a drawing for the chance to 
win the gift card once the study is complete.   
 
10. You do not have to participate in this study if you do not want to. Participation in this 
study is completely voluntary. Even if you begin the testing and wish to withdraw you 
may do so at any point during the study.  
 
11. There are no penalties for removing yourself from the study or denying participation in 
the study.  
 
12. All information will be treated confidentially.  There is one exception to confidentiality 
that we need to make you aware of.  In certain research studies, it is our ethical 
responsibility to report situations of child or elder abuse, child or elder neglect, or any 
life-threatening situation to appropriate authorities. However, we are not seeking this type 
of information in our study nor will you be asked questions about these issues. 
 
 
13. You must be 18 years of age or older to consent to participate in this research study.  If 
you consent to participate in this research study and to the terms above, please sign your 
name and indicate the date below.   
 
You will be given a copy of this consent form to keep for your records.  This project has been 
reviewed and approved by the GSU Institutional Review Board under tracking number H_17089. 
 
Title of Project: The Effect of Stimulant Medication on Reaction Time in   Recreationally Active 
Individuals with ADHD  
Principal Investigator:   
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 Nichole LaFortune, ATC  
 nl01575@georgiasouthern.edu 
 
Other Investigator(s):   
 Dr. George Shaver  
gwshaver@georgiasouthern.edu 
Dr. Barry Munkasy 
bmunkasy@georgiasouthern.edu 
 
Faculty Advisor:   
Dr. Tamerah Hunt 
thunt@georgiasouthern.edu 
  
 
______________________________________  _____________________ 
Participant Signature     Date 
 
I, the undersigned, verify that the above informed consent procedure has been followed. 
 
______________________________________  _____________________ 
Investigator Signature     Date 
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APPENDIX D 
ID Number: ______________________  
Demographic Sheet 
1. What is your gender? 
a. Male 
b. Female 
2. How old are you? 
             
  
3. How tall are you? 
            
  
4. How much do you weigh? 
            
  
5. What is your race?  
a. Black 
b. White  
c. Hispanic  
d. Asian 
e. Other 
6. Do you smoke? 
a. Yes 
b. No 
7. Have you been diagnosed with any mental health issues? (ex. anxiety, depression, etc.) 
a. Yes 
b. No 
8. Are you on any additional medications? (ex. cholesterol, blood pressure, depression etc.) 
a. Yes  
b. No  
9. Have you consumed alcohol in the last 24 hours?  
a. Yes  
b. No 
10. Have you used a pre-workout supplement within the last 24 hour? 
a. Yes 
b. No 
11. Have you had a musculoskeletal injury in the last 6 months? (ex. sprains, strains, etc) 
a. Yes  
b. No  
12. Have you had a head injury in the last 6 months? (ex. Concussion) 
a. Yes  
b. No  
13. Do you meet the criteria for recreationally active? (i.e. participating in some form of physical activity for 20 min three 
times per week.) 
a. Yes  
b. No 
14. How many hours of sleep did you receive last night? 
            
  
15. Do you currently take ADHD medication? 
a. Yes  
b. No 
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If number 15 is answered yes please answer the following questions. 
16. Who diagnosed you with ADHD? (ex. pediatric doctor, psychologist, etc.) 
            
                                                                                       
 
17. What is the name of the medication you are prescribed? 
            
                                                                                       
18. How long have you been on ADHD medication? 
            
                                                                                       
19. How regularly do you take your medication?  
             
  
20. Do you feel as if your medication helps you in ATHLETIC ACTIVITES? 
 
a. Yes  
b. No  
Exclusion Criteria 
• No musculoskeletal or head injuries within the last 6 months 
• Patients prescribed non-stimulant medication 
• Mental health comorbidities (anxiety, depression) 
• No other prescribed medication for other comorbidities (sleep disturbances)   
• Smoking  
• Use of alcohol or recreational drugs within 24 hours of testing 
 
 
 
 
 
 
 
 
 
 
 
 
 
76 
 
 
FOR THE RESEARCHER USE ONLY 
Dominant Hand:________________________ 
Distance from Dynavision:  ___________________ 
Mode D:  
Horizontal  
Visual  Px: 1: 2: 3: 4: 5: 6: 7: 
Motor Px: 1: 2: 3: 4: 5: 6: 7: 
 
Circle 
Visual  Px: 1: 2: 3: 4: 5: 6: 7: 
Motor Px: 1: 2: 3: 4: 5: 6: 7: 
 
Direct  
Visual  Px: 1: 2: 3: 4: 5: 6: 7: 
Motor Px: 1: 2: 3: 4: 5: 6: 7: 
 
Mode A: Px: ____  Px:____  Px: ____  1: ____  2: ____  3: ____  4: ____ 5: ____   
_____________________________________________________________________________________
____________ 
Mode D:  
Horizontal  
Visual  Px: 1: 2: 3: 4: 5: 6: 7: 
Motor Px: 1: 2: 3: 4: 5: 6: 7: 
 
Circle 
Visual  Px: 1: 2: 3: 4: 5: 6: 7: 
Motor Px: 1: 2: 3: 4: 5: 6: 7: 
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Direct  
Visual  Px: 1: 2: 3: 4: 5: 6: 7: 
Motor Px: 1: 2: 3: 4: 5: 6: 7: 
 
 
Mode A: Px: ____  Px:____  Px: ____  1: ____  2: ____  3: ____  4: ____ 5: ____   
 
 
Post Dynavision Effort Scale  
 
1. How hard did you try? 
 
 
0  1  2  3  4  5  6  
 
 
 
 
 
 
First Test Session Answers: 
 1) 
 
2) 
 
3) 
 
 
 
 
 
Did not try at all  Tried my hardest   
Second Test Session Answers: 
 1) 
 
2) 
 
3) 
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Script  
 
Validation of medication: 
• If the participant is supposed to be on medication: Did you take your medication today? 
• If the participant is supposed to be off medication: Did you not take your medication 
today?  
 
Mode D 
• Which hand is your dominant hand?  You will be using your dominant hand for the all 
tasks of the Mode D test.   
 
• Please stand in a comfortable position in front of the LCD screen.  The spot you choose 
will be measured from the board to the tip of the toes.    
• The screen will be adjusted to the height of the participant, where the LCD screen is in 
front of their eyes and they will be able to reach all of the potential stimuli.   
• For this test you will have one practice trial before each of the three tasks.   
• For the first task you will have to respond to stimuli in a horizontal line.  To start this task 
you will hold down the home button.  Once holding down this button a new stimulus will 
appear in a horizontal line (point to potential stimuli) in a matter of 2-4 seconds.  Once 
you see a new stimulus remove your finger from the home button and press the new 
stimulus as quickly as you can.  After you respond to the one stimuli, wait for me to 
instruct you to hold down the red button again to start the next stimulus.  After the one 
practice trial you will repeat this 7 times.   
• When the 7 trials are completed I will progress you to the next task.   
• You will be given 30 seconds rest before starting the next task.   
• For the second task you will be responding to the stimuli in a circle (point to potential 
stimuli).  Again, you will hold down the home button to start the task.  Within 2-4 
seconds a new stimulus will appear and you must try to strike it as quickly as possible.  
After you respond to the one stimuli, wait for me to instruct you to hold down the red 
button again to start the next stimulus.  After the one practice trial you will repeat this 7 
times.  You will be given 30 seconds of rest before starting the next task.   
• For the final task you will be responding to a direct stimulus.  You will know before the 
test starts which button you will need to hit.  Once holding down the home button the 
new stimulus will appear in a matter of 2-4 seconds.  You will perform one practice trial 
followed by 7 stimuli, again striking the new stimulus as quickly as possible.  After you 
respond to the one stimuli, wait for me to instruct you to hold down the red button again 
to start the next stimulus.   
• This concludes this portion of the testing. 
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Mode A 
• Please stand in a comfortable position where you are able to reach both sides as well as 
the top and the bottom of the board with both hands.   
• For this test you will be allowed to use both hands for this test.  You will also be allowed 
to either use the front or the back of your hand.  Whichever you choose you will need to 
continue with that method for the entity of the test and the next test session.     
• For this test you must try your hardest to continuously look at the LCD screen.  (this will 
be repeated before each of the test trials begin.   
• The LCD screen will countdown from 5 and a red button will light up.  You must try to 
strike that button as quickly as you can.  Once the button is struck, the red light will move 
to a different part of the board, where again you must try to strike the button as quickly as 
you can.  This process will continue for a total of 1 minute.  You will perform 3 practice 
trials followed by 5 test trials.  Again, you must try to hit the buttons as quickly as 
possible while keeping your eye sight on the LCD screen.   
 
Effort Debriefing 
• If you had to rank how hard you tried on a 0-6 scale, 0 being not trying at all and 6 being you put 
forth your best effort, how would you rank your efforts?  
o Where there any points in which you felt you stopped trying your hardest? If so, 
which sections?  
o Did you feel as if you lost attention/interest during any of the testing sessions? If, 
so which sections?   
o Do you feel your loss of attention/ interest affected your effort? 
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